Impact of cardiometabolic multimorbidity and ethnicity on cardiovascular/renal complications in patients with COVID-19
Heart Dec 21, 2021
Norris T, Razieh C, Zaccardi F, et al. - In this study of patients hospitalized with COVID-19, cardiovascular complications or death affected just under half of all patients, with highest risk evident in South Asians or Blacks and in those having cardiometabolic multimorbidity.
In this multicentre, prospective cohort study in 302 UK healthcare facilities, a total of 65,624 adult patients hospitalized with COVID-19 were included, of which 44,598 (68.0%) had at least one cardiometabolic condition on admission.
Occurrence of cardiovascular (heart failure, arrhythmia, cardiac ischaemia, cardiac arrest, coagulation complications, stroke)/renal complications or death was reported in 38.0% (n=24,609) of patients.
Independent association of baseline cardiometabolic conditions with elevated odds of in-hospital complications was found, and elevation in this risk was evident in the presence of cardiometabolic multimorbidity.
A 1.46, 2.04 and 3.10 times higher odds of any cardiovascular/renal complication was observed in relation to 1, 2 or ≥3 cardiometabolic conditions, respectively, vs having no cardiometabolic conditions.
For all-cause mortality, a similar pattern was seen.
Higher risk of any cardiovascular/renal complication was found in the South Asian (OR 1.19) and black (OR 1.53) ethnic groups, vs the white group.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries